Evidence map›Paper›PMID 38831300›Full record

ArticleBMC endocrine disorders2024

Factors associated with glycemic control in patients with T2DM: evidence from a cross-sectional study in China.

Wenting Luo, Jiayu Zhang, Yanxing Luo, Qiuwan Wu, Longfei Chen, Changqin Liu, Minqiang Lin

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenting Luo *Department of Scientific Research, School of Medicine, the First Affiliated Hospital of Xiamen University, Xiamen University, No.24, Bailu Road, Siming District, Xiamen, 361003, Fujian, China.
Jiayu Zhang *Department of Intensive Care Medicine, School of Medicine, the First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361003, China.
Yanxing Luo *School of Public Health, Fujian Medical University, Fuzhou, 350122, China.
Qiuwan WuDepartment of Scientific Research, School of Medicine, the First Affiliated Hospital of Xiamen University, Xiamen University, No.24, Bailu Road, Siming District, Xiamen, 361003, Fujian, China.
Longfei ChenDepartment of Scientific Research, School of Medicine, the First Affiliated Hospital of Xiamen University, Xiamen University, No.24, Bailu Road, Siming District, Xiamen, 361003, Fujian, China.
Changqin LiuDepartment of Endocrinology and Diabetes, School of Medicine, the First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361003, China.
Minqiang LinDepartment of Scientific Research, School of Medicine, the First Affiliated Hospital of Xiamen University, Xiamen University, No.24, Bailu Road, Siming District, Xiamen, 361003, Fujian, China. linmqxmkyb@163.com.

Funding

Fujian Provincial Health Science and Technology Project 2022CXB016High-quality development Funds of The First Affiliated Hospital of Xiamen University YN81870611
6 · The paper itself

Abstract

objectiveThis study aimed to analyze the factors influencing glycemic control in patients with type 2 diabetes mellitus (T2DM).

methodsBaseline data, encompassing basic information, lifestyle habits, and treatment of 305 T2DM patients from March 2021 to January 2023, were collected and analyzed using SPSS 26.0 software.

resultsUnivariate and multivariate logistic regression analyses identified insulin therapy (OR = 2.233; 95%Cl = 1.013-4.520; P = 0.026) and regular clinic visits (OR = 0.567; 95%Cl = 0.330-0.973; P = 0.040) as independent factors influencing glycemic control. No observed interactions between the two variables were noted.

conclusionHistory of insulin therapy and regular clinic visits were significantly and independently associated with glycated hemoglobin control in T2DM patients. Tailored interventions based on individual circumstances are recommended to optimize glycemic control.

Indexed as

Blood GlucoseDiabetes Mellitus, Type 2Glycated HemoglobinGlycemic ControlHypoglycemic AgentsAdultAgedChinaCross-Sectional StudiesFemaleHumansInsulinMaleMiddle AgedPrognosisBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulinDiabetesGlucose controlInfluencing factorsPatient management

Identifiers

PMID38831300
PMCPMC11149194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.